A Swiss startup is creating computer processors using living neurons from human skin Instead of relying on digital chip processors, a Swiss startup called FinalSpark believes the world needs biological ones that use much less energy. FinalSpark says that it has tested 10 million living neurons and that research work is already underway on building…
New treatment for myasthenia gravis
UCB receives CHMP positive opinion for rozanolixizumab for treatment of adults with generalized myasthenia gravis in Europe 10th November 2023; UCB announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending granting marketing authorisation for rozanolixizumab as an add-on to standard therapy…
Advanced Parkinson’s disease: NICE backs treatment
27 October, 2023: The National Institute for Health and Care Excellence (NICE) has recommended a treatment for advanced Parkinson’s disease that could benefit approximately 900 patients in England. This was the first technology appraisal from NICE to look at a treatment for Parkinson’s disease. Final draft guidance suggests that foslevodopa–foscarbidopa (Produodopa, AbbVie) should be an…
AI medical devices – MHRA to launch the AI-Airlock
Regulatory sandbox for AI developers will assist in the development and deployment of software and AI medical devices, safely providing patients with earlier access to cutting edge innovations that improve care. The Medicines and Healthcare products Regulatory Agency (MHRA) has announced it is taking forward its new ‘regulatory sandbox’, the AI-Airlock, that will provide a…
Could shared medical appointments increase patient engagement?
New research from ESMT Berlin finds that shared medical appointments increase engagement from patients as they ask more questions, make more comments, and exhibit higher levels of nonverbal engagement, providing greater value for other patients in the sessions. One-on-one service delivery is often considered ideal, with individualised attention assumed to improve client outcomes. In shared service delivery,…
David Martin, CEO of the MS Trust to retire
David Martin has announced that following six years at the MS Trust, he plans to retire in early 2024. During his tenure at the MS Trust, David has overseen the establishment of both the Specialist Nurse and the Advanced MS Champion programmes. Working closely with the NHS, these schemes place Specialist MS Health Professionals in…
Ipsen and World Stroke Organisation partnership focuses on improving post-stroke care
Research highlights financial challenges and knowledge gaps faced by stroke survivors Results of a new Ipsen survey highlight the stark reality faced by stroke survivors, revealing the personal and financial burdens that stroke can have on individuals and their families. The survey raises critical concerns, suggesting that many stroke survivors are not proactively made aware…
Increase Rehabilitation Time for Stroke Patients – NICE
The amount of rehabilitation time offered to adults in England who have had a stroke should be significantly increased from previous recommendations, the National Institute for Health and Care Excellence (NICE) said. Previous guidance from 2013 recommended initially offering at least 45 minutes of relevant stroke rehabilitation therapy for a minimum of 5 days per…
Are CGRP medications effective against migraine in men?
Via Medscape: Most patients with migraine are women. This female predominance is reflected in the clinic and in clinical trials, where ~85% are women. A pharmacologist and a neurologist from the United States argue that the efficacy of calcitonin gene-related peptide (CGRP)-based migraine therapies has been proven in women but not in men, and that men should be informed…
